Tuesday, April 14, 2015 11:02:32 AM
thx too Infinity and rr. below some links to various MDM2-p53 articles, some of which i'm sure have been posted before. the first seems the best overview based on my cursory review --- comprehensive and gets to the MDM2-MDMX interplay. still learning up on the science.
///
Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics (2012)
http://1drv.ms/1GGSt04
xxxxxxxxxxxxx
MDM2-p53 Interaction in Peadiatric Solid Tumous: Preclinical Rationale, Biomarkers and Resistance (2014) (Note: this has been posted before / refs Kevetrin) (PDF)
http://www.ingentaconnect.com/content/ben/cdt/2014/00000015/00000001/art00010?crawler=true
Targeting MDM2-p53 interaction for cancer therapy: are we there yet? (2014) (abstract only)
http://www.ncbi.nlm.nih.gov/pubmed/24180275
Small molecule agents targeting the p53-MDM2 pathway for cancer therapy. (2012) (abstract only)
http://www.ncbi.nlm.nih.gov/pubmed/23059763
Targeting the MDM2–p53 interaction as a therapeutic strategy for the treatment of cancer (2010)
http://www.dovepress.com/targeting-the-mdm2ndashp53-interaction-as-a-therapeutic-strategy-for-t-peer-reviewed-article-CHC
http://www.dovepress.com/getfile.php?fileID=6660 (PDF, Full)
Targeting the MDM2-p53 Interaction for Cancer Therapy (2009)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676446/
The MDM2-p53 Interaction (2003)
http://mcr.aacrjournals.org/content/1/14/1001.full
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM